Global Pricing

The global AI in biotechnology market is projected to reach USD 7.75 billion by 2029 from USD 3.23 billion in 2024, at a high CAGR of 19.1% during the forecast period. The market is expected to grow as a result of the increasing demand for personalized therapies and precision medicines, and the grow ...

Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024–2029 Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Service Platforms Drive Pharmaceutical Commercialization With the growing preference for a patient-centric care delivery approach, t ...

The 2025-2030 World Outlook for Vaccines Sales This study covers the world outlook for vaccines sales across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ...

Cloud Computing in Healthcare Market by Product (Healthcare Payer Solutions, Healthcare Provider Solutions), Component (Services, Software), Pricing Model, SERVICE MODEL, Deployment Model - Global Forecast 2024-2030 The Cloud Computing in Healthcare Market size was estimated at USD 49.40 billion in ...

Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027 (Global Almanac) Summary Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile als ...

Impact of Inflation on the Healthcare Sector by Physicians Perspective, Patient Treatment, Regional Analysis, Drug Prices and Treatment Costs - Thematic Intelligence Summary In this Inflation in the Healthcare Sector - Physician Perspective report-tracker, GlobalData continues to examine the impact ...

Vaccine Market Report 2022 Market At-A-Glance In 2020, the global vaccine market was valued at $35.9 billion. Fueled by the pandemic, the prevalence of other diseases, and research and development the market is expected to more than double to $83.5 billion by 2027. The U.S. alone is projected to rea ...

IDC Perspective: Real-World Evidence and Drug Pricing in 2022 This IDC Perspective discusses real-world evidence and drug pricing in 2022. Prescription drug pricing, especially in the United States, has become a widely discussed issue for patients, private and government healthcare payers, life scie ...

NASH Drug Pipeline and Market Overview Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifi ...